Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-07T20:28:09.912Z Has data issue: false hasContentIssue false

Differences in efficacy, resistance mechanism and target protein interaction between two PPO inhibitors in Palmer amaranth (Amaranthus palmeri)

Published online by Cambridge University Press:  13 January 2020

Chenxi Wu*
Affiliation:
Bayer CropScience, St Louis, MO, USA
Michael-Rock Goldsmith
Affiliation:
Bayer CropScience, St Louis, MO, USA
John Pawlak
Affiliation:
Valent USA, Walnut Creek, CA, USA
Paul Feng
Affiliation:
Bayer CropScience, St Louis, MO, USA
Stacie Smith
Affiliation:
Bayer CropScience, St Louis, MO, USA
Santiago Navarro
Affiliation:
Bayer CropScience, St Louis, MO, USA
Alejandro Perez-Jones
Affiliation:
Bayer CropScience, St Louis, MO, USA
*
Author for correspondence: Chenxi Wu, Bayer CropScience, 700 Chesterfield Parkway West, St Louis, MO63017. Email: chenxi.wu@bayer.com
Rights & Permissions [Opens in a new window]

Abstract

A weed survey was conducted on 134 Palmer amaranth (Amaranthus palmeri S. Watson) populations from Mississippi and Arkansas in 2017 to investigate the spread of resistance to protoporphyrinogen oxidase (PPO) inhibitors using fomesafen as a proxy. Fomesafen resistance was found in 42% of the A. palmeri populations. To investigate the resistance basis of different PPO inhibitors, we further characterized 10 representative populations by in planta bioassay in a controlled environment and molecular characterizations (DNA sequencing and TaqMan® gene expression assay). A total of 160 plants were sprayed with a labeled field rate (1X) of fomesafen or salfufenacil and screened for the presence of three known resistance-endowing mutations in the mitochondrial PPX2 gene (ΔGly-210, Arg-128-Gly, Gly-399-Ala). To compare the potencies of fomesafen and saflufenacil, dose–response studies were conducted on two highly resistant and one sensitive populations. The interaction of the two herbicides with the target protein harboring known PPX2 mutations was also analyzed. Our results showed that: (1) 90% of the fomesafen- or saflufenacil-resistant plants have at least one of the three known PPX2 mutations, with ΔGly-210 being the most prevalent; (2) saflufenacil is more potent than fomesafen, with five to nine times lower resistance/susceptible (R/S) ratios; (3) fomesafen selects for more diverse mutations, and computational inhibitor/target modeling of fomesafen suggest a weaker binding affinity in addition to a smaller interaction volume and volume overlap with the substrate protoporphyrinogen IX than saflufenacil. As a result, saflufenacil shows reduced sensitivity to PPX2 target-site mutations. Results from current study can help pave the way for designing weed management strategies to delay resistance development and maintain the efficacy of PPO inhibitors.

Information

Type
Research Article
Copyright
© Weed Science Society of America, 2020
Figure 0

Table 1. Location and GPS coordinates for the 10 Amaranthus palmeri populations selected for further greenhouse and molecular characterization.

Figure 1

Figure 1. Survey of resistance to fomesafen on 134 Amaranthus palmeri populations from Arkansas and Mississippi. Plants were sprayed with fomesafen at 420 g ha−1, and herbicide response was calculated as means of viusal control (%) of eight plants from each population, and categorized into four resistance levels: red, high resistance, <50% of control;yellow, moderate resistance, 50%−85% of control; light green, 85%−95% of control, low resistance; and dark green, >95% of control, sensitive.

Figure 2

Figure 2. Distribution of different PPX2 mutations in the survivors across different populations. N is the number of survivors for each population; the solid black bar represents ΔGly-210; the solid gray bar represents Arg-128-Gly; the dotted white bar represents Gly-399-Ala; the solid white bar represents a double mutation of ΔGly-210 + Arg-128-Gly; and the dashed bar represents unknown mechanisms.

Figure 3

Figure 3. Dose−response studies of fomesafen and saflufenacil on two highly resistant and one susceptible Amaranthus palmeri populations. (A) Dose−response curves fit on visual injuiry of two herbicides on the three A. palmeri populations; (B) photos of the dose−response study taken at 21 DAT. UTC, untreated control.

Figure 4

Figure 4. Comparison of herbicide efficacy and resistance genetic basis for the two protoporphyrinogen oxidase (PPO) herbicides. The left panels (A and B) shows distributions of resistance levels in the survivors of each herbicide out of 80 sprayed plants (fomesafen: N = 31; saflufenacil: N = 6); the right panels (C and D) show the distribution of three PPX2 mutations among the survivors.

Figure 5

Figure 5. Ligand interaction diagram of substrate within the active site (6.5 Å). Ligand interaction map of Amaranthus palmeri PPX2 homology model with bound protoporphyrinogen substrate showing all residues within 6.5 Å from the substrate. Other prospective mutants could, in theory, be modeled in silico and tested using the same protocol.

Figure 6

Table 2. Protein modeling work on different PPO inhibitors.

Figure 7

Figure 6. Protein modeling of PPX2 and deletion effects on overlap. (a) Chemical structure of the protoporphyrinogen oxidase (PPO) substrate protoporphyrinogen and two inhibitors; (b) pose analysis to show the competition for the volume with the substrate; (c) volume coverage and intercept volume.

Figure 8

Figure 7. Distribution of three PPX2 mutations in both resistant and sensitive plants for fomesafen and salfufenacil. N is the total number of all three PPX2 mutations found among 80 total plants; the black bar represents resistant plants and the white bar represents sensitive plants.